Urgency for Advancements in Psychedelic Therapies

Amanda Feilding is a drug policy reformer, lobbyist and research coordinator. She has been an advocate for psychedelics since the 60s and, in 1998, founded the Beckley Foundation. The foundation supports neuroscientific and clinical research into the effects of psychedelics on the brain and mind and has been behind many of the scientific breakthroughs in the psychedelic renaissance, including first trial of psilocybin for treatment-resistant depression and the first ever scans of the brain on LSD. Today we talk about all the great work that Amanda and the Beckley foundation have been doing over the years.